These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24480310)

  • 1. Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy.
    Moore RK; Abdullah S; Tardiff JC
    Arch Biochem Biophys; 2014 Jun; 552-553():21-8. PubMed ID: 24480310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FRET-based analysis of the cardiac troponin T linker region reveals the structural basis of the hypertrophic cardiomyopathy-causing Δ160E mutation.
    Abdullah S; Lynn ML; McConnell MT; Klass MM; Baldo AP; Schwartz SD; Tardiff JC
    J Biol Chem; 2019 Oct; 294(40):14634-14647. PubMed ID: 31387947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.
    Moore RK; Grinspan LT; Jimenez J; Guinto PJ; Ertz-Berger B; Tardiff JC
    J Mol Cell Cardiol; 2013 May; 58():188-98. PubMed ID: 23434821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of troponin T cardiomyopathy mutations on the calcium sensitivity of the regulated thin filament and the actomyosin cross-bridge kinetics of human β-cardiac myosin.
    Sommese RF; Nag S; Sutton S; Miller SM; Spudich JA; Ruppel KM
    PLoS One; 2013; 8(12):e83403. PubMed ID: 24367593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular effects of familial hypertrophic cardiomyopathy-related mutations in the TNT1 domain of cTnT.
    Manning EP; Tardiff JC; Schwartz SD
    J Mol Biol; 2012 Aug; 421(1):54-66. PubMed ID: 22579624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.
    Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca
    Sparrow AJ; Watkins H; Daniels MJ; Redwood C; Robinson P
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H715-H722. PubMed ID: 32083971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of molecular and functional effects of mutations in cardiac troponin T linked to familial hypertrophic cardiomyopathy: an integrative in silico/in vitro approach.
    Manning EP; Guinto PJ; Tardiff JC
    J Biol Chem; 2012 Apr; 287(18):14515-23. PubMed ID: 22334656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region.
    Gangadharan B; Sunitha MS; Mukherjee S; Chowdhury RR; Haque F; Sekar N; Sowdhamini R; Spudich JA; Mercer JA
    Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11115-11120. PubMed ID: 28973951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca(2+)-regulatory function of the inhibitory peptide region of cardiac troponin I is aided by the C-terminus of cardiac troponin T: Effects of familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT R278C, alone and in combination, on filament sliding.
    Brunet NM; Chase PB; Mihajlović G; Schoffstall B
    Arch Biochem Biophys; 2014 Jun; 552-553():11-20. PubMed ID: 24418317
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Madan A; Viswanathan MC; Woulfe KC; Schmidt W; Sidor A; Liu T; Nguyen TH; Trinh B; Wilson C; Madathil S; Vogler G; O'Rourke B; Biesiadecki BJ; Tobacman LS; Cammarato A
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18822-18831. PubMed ID: 32690703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin Overlap.
    McConnell M; Tal Grinspan L; Williams MR; Lynn ML; Schwartz BA; Fass OZ; Schwartz SD; Tardiff JC
    Biochemistry; 2017 Jul; 56(26):3403-3413. PubMed ID: 28603979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
    Lombardi R; Bell A; Senthil V; Sidhu J; Noseda M; Roberts R; Marian AJ
    Cardiovasc Res; 2008 Jul; 79(1):109-17. PubMed ID: 18349139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac troponin T N-domain variant destabilizes the actin interface resulting in disturbed myofilament function.
    Landim-Vieira M; Ma W; Song T; Rastegarpouyani H; Gong H; Coscarella IL; Bogaards SJP; Conijn SP; Ottenheijm CAC; Hwang HS; Papadaki M; Knollmann BC; Sadayappan S; Irving TC; Galkin VE; Chase PB; Pinto JR
    Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2221244120. PubMed ID: 37252999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy mutations increase myofilament Ca
    Robinson P; Liu X; Sparrow A; Patel S; Zhang YH; Casadei B; Watkins H; Redwood C
    J Biol Chem; 2018 Jul; 293(27):10487-10499. PubMed ID: 29760186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
    Redwood CS; Moolman-Smook JC; Watkins H
    Cardiovasc Res; 1999 Oct; 44(1):20-36. PubMed ID: 10615387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.
    Redwood C; Lohmann K; Bing W; Esposito GM; Elliott K; Abdulrazzak H; Knott A; Purcell I; Marston S; Watkins H
    Circ Res; 2000 Jun; 86(11):1146-52. PubMed ID: 10850966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
    O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
    J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
    Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
    Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.